The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD)

Journal of Gastroenterology

Volumn 50, Issue 8, 2015, Pages 903-912

  Liccardo, D ^a   Mosca, A ^a   Petroni, S ^a   Valente, P ^a   Giordano, U ^a   Mico' A G A ^b   Pescosolido, S ^c   Buzzonetti, L ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b ASL Roma B   (Italy)

^c ASL RM D ^*  (Italy)

Author keywords

Hypertensive retinopathy; Metabolic syndrome; Microvascular complications; Non alcoholic fatty liver disease; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MONITORING; BODY MASS; CHILDHOOD OBESITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETINA BLOOD VESSEL; RETINOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANTHROPOMETRY; ARTERY; BIOPSY; CHILD; COMPLICATION; CONGENITAL MALFORMATION; FEMALE; HYPERTENSIVE RETINOPATHY; JOINT INSTABILITY; LIVER; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, GENETIC; VASCULAR MALFORMATIONS;

ADOLESCENT; ANTHROPOMETRY; ARTERIES; BIOPSY; BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; FEMALE; HUMANS; HYPERTENSIVE RETINOPATHY; JOINT INSTABILITY; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RETINAL VESSELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN DISEASES, GENETIC; VASCULAR MALFORMATIONS;

EID: 84938864127     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-014-1024-1     Document Type: Article

References (52)

1. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002;360:473–82.
2. Gopinath B, Baur LA, Teber E, et al. Effect of obesity on retinal vascular structure in pre-adolescent children. Int J Pediatr Obes. 2011;6(2–2):e353–9.
3. Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol. 2007;17(11):863–9.
4. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7(4):195–203.
5. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012;54:700–13.
6. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–9.
7. Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology. 2006;49:450–65.
8. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
9. Kleiner DE, Brunt EM, van Natta M, et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
10. Nobili V, Svegliati-Baroni G, Alisi A, et al. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58(6):1218–29.
11. Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med. 2012;44(1):29–40.
12. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and non-alcoholic fatty liver disease in children. Curr Opin Pediatr. 2009;21:529–35.
13. Alisi A, Nobili V. Overlapping clinical features between NAFLD and metabolic syndrome in children. EMJ Hepatol. 2014;1:55–61.
14. Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric non-alcoholic fatty liver disease metabolic syndrome and cardiovascular risk. World J Gastroenterol. 2011;17(26):3082–91.
15. Wong TY, Barr EL, Tapp RJ, Harper CA, Taylor HR, Zimmet PZ, Shaw JE, et al. Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol. 2005;140:1157–9.
16. Wong TY, Klein R, Islam FM, et al. Three-year incidence and cumulative prevalence of retinopathy: the Atherosclerosis Risk in Communities study. Am J Ophthalmol. 2007;143:970–6.
17. Cheung N, Saw SM, Islam FM, et al. BMI and retinal vascular caliber in children. Obesity Silver Spring. 2007;15(1):209–15.
18. Wang JJ, Taylor B, Wong TY, et al. Retinal vessel diameters and obesity: a population-based study in older persons. Obesity (Silver Spring). 2006;14(2):206–14.
19. Shore AC, Tooke JE. Microvascular function in human essential hypertension. J Hypertens. 1994;12:717–28.
20. Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99:1873–9.
21. Antonios TF, Singer DR, Markandu ND, et al. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999;34:655–8.
22. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104:735–40.
23. Yu T, Mitchell P, Berry G, et al. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;16:83–9.
24. Wong TY, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older persons: the Cardiovascular Health Study. Ophthalmology. 2003;110:658–66.
25. Klein R, Klein BE, Moss SE, et al. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112:92–8.
26. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939;197:332–43.
27. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310–7.
28. Katsi V, Vlachopoulos C, Souretis G, et al. Association between retinal microcirculation and aortic stiffness in hypertensive patients. Int J Cardiol. 2012;157(3):370–3.
29. Leung H, Wang JJ, Rochtchina E, et al. Relationships between age, blood pressure, and retinal vessel diameters in an older population. Invest Ophthalmol Vis Sci. 2003;44(7):2900–4.
30. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabetes Med. 2007;24:137–44.
31. Kawasaki R, Wang JJ, Rochtchina E, et al. Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study. Ophthalmology. 2006;13:1378–84.
32. van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care. 2002;25:1320–5.
33. De Jongh RT, Serne EH, IJzerman RG, et al. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation. 2004;109:2529–35.
34. Daniels SR, Lipman MJ, Burke MJ, Loggie JM. The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol. 1991;111:205–8.
35. Skalina ME, Annable WL, Kliegman RM, Fanaroff AA. Hypertensive retinopathy in the newborn infant. J Pediatr. 1983;103:781–6.
36. Băloşeanu CL, Streba CT, Vere CC, Comănescu V, Rogoveanu I. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol. 2012;53(3):609–14.
37. Centers for Disease Control and Prevention. About BMI for children and teens [cited 2013 Jul 13]. Available http://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.
38. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Childhood. 1995;73:25–9.
39. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
40. Giordano U, Della CC, Cafiero G, et al. Association between nocturnal blood pressure dipping and insulin resistance in children affected by NAFLD. Eur J Pediatr. 2014;173(11):1511–8.
41. Taarnhoj NCBB, Munch IC, Sander B, et al. Straight versus tortuous retinal arteries in relation to blood pressure and genetics. Br J Ophthalmol. 2008;92:1055–60.
42. Wilkinson CP, Ferris FL, Klein RE, et al. Global diabetic retinopathy project group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677–82.
43. Brunner EJ, Shipley MJ, Witte DR, et al. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care. 2006;29:26–31.
44. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria: the DECODE study group: European Diabetes Epidemiology Group: Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet. 1999;354:617–21.
45. Gu D, Wildman RP, Wu X, et al. Incidence and predictors of hypertension over 8 years among Chinese men and women. J Hypertens. 2007;25:517–23.
46. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
47. Targher G, Bertolini L, Padovani R, et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care. 2004;27(10):2498–500.
48. Targher G, Bertolini L, Padovani R, et al. Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol. 2005;25(12):2687–8.
49. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes Care. 2007;30(10):2708–15.
50. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369(9559):425–35.
51. Gopinath B, Baur LA, Wang JJ, et al. Blood pressure is associated with retinal vessel signs in preadolescent children. J Hypertens. 2010;28(7):1406–12.
52. Manco M, et al. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis. 2010;209:463–8.